Proteases
-   A8201 Amprenavir (agenerase)Summary: HIV-1 protease inhibitor A8201 Amprenavir (agenerase)Summary: HIV-1 protease inhibitor
-   A4023 LY30394781 CitationTarget: NotchSummary: Notch inhibitor, novel and potent A4023 LY30394781 CitationTarget: NotchSummary: Notch inhibitor, novel and potent
-   A1924 Z-WEHD-FMK1 CitationSummary: Caspase 5 inhibitor,potent,cell-permeable and irreversible A1924 Z-WEHD-FMK1 CitationSummary: Caspase 5 inhibitor,potent,cell-permeable and irreversible
-   A3690 OtamixabanTarget: Factor XaSummary: Direct factor Xa inhibitors,potent and selective A3690 OtamixabanTarget: Factor XaSummary: Direct factor Xa inhibitors,potent and selective
-   A3820 Simeprevir1 CitationTarget: HCV ProteasesSummary: Inhibitor of HCV NS3/4A protease A3820 Simeprevir1 CitationTarget: HCV ProteasesSummary: Inhibitor of HCV NS3/4A protease
-   A4061 IPI-504 (Retaspimycin hydrochloride)3 CitationTarget: HSP90Summary: Hsp90 inhibitor,novel, potent,selective A4061 IPI-504 (Retaspimycin hydrochloride)3 CitationTarget: HSP90Summary: Hsp90 inhibitor,novel, potent,selective
-   A4074 S/GSK1349572Summary: HIV integrase inhibitor, novel and potent A4074 S/GSK1349572Summary: HIV integrase inhibitor, novel and potent
-   B5692 Hexa-D-arginine TFASummary: furin inhibitor B5692 Hexa-D-arginine TFASummary: furin inhibitor
-   A4433 ARP 1011 CitationSummary: MMP inhibitor,potent and selective A4433 ARP 1011 CitationSummary: MMP inhibitor,potent and selective
-   A4413 PD 150606Target: CalpainsSummary: Non-peptide calpain inhibitor A4413 PD 150606Target: CalpainsSummary: Non-peptide calpain inhibitor
